2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shah MH and Paradkar A | Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. | 2007 | Eur J Pharm Biopharm | pmid:17353118 |
| Nielsen LH et al. | Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. | 2017 | Eur J Pharm Biopharm | pmid:27993733 |
| Lopes LB et al. | Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. | 2005 | Eur J Pharm Biopharm | pmid:15848052 |
| Steluti R et al. | Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. | 2005 | Eur J Pharm Biopharm | pmid:15996585 |
| Ahmed AR et al. | Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. | 2008 | Eur J Pharm Biopharm | pmid:18692569 |
| Onoue S et al. | Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. | 2012 | Eur J Pharm Biopharm | pmid:22008148 |
| Esposito E et al. | Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. | 2014 | Eur J Pharm Biopharm | pmid:24361485 |
| Carneiro C et al. | DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. | 2015 | Eur J Pharm Biopharm | pmid:25499956 |
| Rizwan SB et al. | Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. | 2011 | Eur J Pharm Biopharm | pmid:21237267 |
| Donida B et al. | Monoolein-based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment. | 2018 | Eur J Pharm Biopharm | pmid:30315863 |